2014 | Medical Innovation Summit

Now, it's Personal

Cancer Treatment and Personalized Medicine October 27-29, 2014 Cleveland, Ohio

 
  • Download Our FREE Mobile App

    Stay connected. Download today!

    appleStore.pnggooglePlay.png
  • 2014 Summit Preview

    Join more than 1,500 senior executives, investors, entrepreneurs and clinicians who will gather in Cleveland to discuss investable innovations that can lead to the detection and treatment of cancer. The 2014 Summit will include:
     

    • Detailed insights into the latest breakthroughs of personalized medicine
    • Discussions with world leaders responsible for the change in healthcare technology.
    • Top 10 Medical Innovations for 2015
       

2013 Speakers

| View All Speakers

Peter Tippett, MD

Chief Medical Officer, Verizon Communications

Peter Tippett, MD | Chief Medical Officer, Verizon Communications ,

Dr. Tippett is Vice President of The Verizon Incubator and is Verizon’s Chief Medical Officer. He is responsible for Verizon’s healthcare strategy and the development of an extensive portfolio of solutions that enable the rapidly evolving healthcare information technology ecosystem.

Dr. Tippett has worked as an emergency room doctor and as a helicopter emergency physician and carries a California physician and surgeon license. His PhD work included the discovery and modelling of new regulatory mechanisms for glucose by the enzyme glucokinase. He worked for Nobel Laureates Robert Bruce Merrifield (chemistry, 1984) and Stanford Moore (chemistry, 1972) at Rockefeller University where Dr. Tippett was the first person to synthesize an active segment of an immunoglobulin. Earlier, he worked in the Charles Glueck laboratory in Cincinnati where he was one of the first individuals to research and consume “sucrose-octa-ester” (now called Olestra).

Dr. Tippett obtained a BS in biology from Kalamazoo College, and a MD and PhD in biochemistry from Case Western Reserve University. He is board certified in internal medicine.

Mark Bertolini

Chairman, CEO and President, Aetna

Mark Bertolini | Chairman, CEO and President, Aetna ,

Mark T. Bertolini is Chairman, Chief Executive Officer and President of Aetna, a Fortune 100 diversified healthcare benefits company. Aetna serves approximately 37.3 million people with information and resources to help them make better informed decisions about their healthcare and has a workforce of approximately 34,000 with operations in North America, Asia, Europe and the Middle East.

Mr. Bertolini joined Aetna in 2003 as head of Aetna’s Specialty Products. Prior to Aetna, Mr. Bertolini held executive positions at Cigna, NYLCare Health Plans, and SelectCare, Inc., where he served as President and Chief Executive Officer.

Recognized as an accessible, forward-thinking and solutions-oriented leader, Mr. Bertolini is actively engaged in the national dialogue on healthcare reform. Mr. Bertolini meets regularly with state and federal policymakers to advocate for measures that increase access, lower costs and improve quality of healthcare. He is a strong advocate of market-based solutions, the expansion and use of health information technology, and the sustainability of the employer-based system.

Mr. Bertolini holds a BA in business administration/finance from Wayne State University and an MBA in finance from Cornell University.

Peter Orszag, PhD

Vice Chairman, Corporate and Investment Banking, Citigroup

Peter Orszag, PhD | Vice Chairman, Corporate and Investment Banking, Citigroup ,

Peter R. Orszag is Vice Chairman of Corporate and Investment Banking, Chairman of the Public Sector Group and Chairman of the Financial Strategy and Solutions Group at Citigroup, Inc. He is also a Contributing Columnist at Bloomberg View, a Distinguished Scholar at the NYU School of Law and an Adjunct Senior Fellow at the Council on Foreign Relations. He previously served as the Director of the Office of Management and Budget in the Obama Administration, and as Director of the Congressional Budget Office. Dr. Orszag graduated summa cum laude in economics from Princeton University and obtained a PhD in economics from the London School of Economics, which he attended as a Marshall Scholar. He is a member of the Institute of Medicine of the National Academies of Sciences, and serves on the Board of Directors of the Peterson Institute for International Economics, the Mt. Sinai Medical Center in New York, the Robert Wood Johnson Foundation, New Visions for Public Schools, ideas42, and the Partnership for Public Service.

Why Attend?

The Medical Innovation Summit provides an unrivaled perspective on the newest medical innovations and the financial drivers behind those innovations. The conference is recognized for providing singular insights, networking opportunities and actionable take away for all participants. The content is designed for:

  • Senior executives in the healthcare industry
  • Clinical, medical affairs, regulatory and business development executives
  • Venture capitalists and angel investor groups
  • Investment bankers
  • Buy-side and sell-side researchers
  • Consulting, legal and other service providers

Agenda Highlights

Monday | October 27th
  • New Ventures Healthcare Challenge
  • The State of Healthcare Innovation
  • Dinner and Keynote Address
Tuesday | October 28th
  • Live Surgery
  • The Business of Cancer Diagnostics
  • Imaging and Cancer Detection
  • Networking Recepton
Wednesday | October 29th
  • Therapeutics and Pharmaceuticals
  • Radiation
  • Revealing of the Top 10 Medical Innovations for 2015

2013 Sponsors

View All Past Sponsors

PREMIER
SPONSORS
PLATINUM
SPONSORS